Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 47Gastrointestinal 42Head & Neck 11Gynecologic 11Thoracic 10Other hematologic neoplasm 9Tumor-Agnostic 8Genitourinary 6Lymphoid 5Endocrine 3CNS 3Sarcoma 2Plasma cell 1Other solid neoplasm 1Other neoplasm 1Other 1NET 1Dermatologic 1Classical hematology 1

Conditions

Thyroid Neoplasms 1Pneumothorax 1Pleural Neoplasms 1Parathyroid Neoplasms 1Mesothelioma 1

Interventions

Cisplatin 147pembrolizumab 129Carboplatin 126Injections 108Pemetrexed 99Paclitaxel 97Gemcitabine 85Irinotecan 75Cyclophosphamide 72Nivolumab 71Docetaxel 68Bevacizumab 59Oxaliplatin 50Fluorouracil 50Capecitabine 48atezolizumab 46Leucovorin 42Etoposide 42tislelizumab 40toripalimab 36fludarabine 32Drug Therapy 32Ipilimumab 30Topotecan 29durvalumab 28Vincristine 27Specimen Handling 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Control Groups × Other solid neoplasm × Clear all
NCT01776385 2018-07-23

The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma

Centre Hospitalier Universitaire de Nice

Phase NA Completed
9 enrolled
Head & NeckOther solid neoplasmThoracic

Mesothelioma, Parathyroid Neoplasms, Pleural Neoplasms, Pneumothorax, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡